By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Platypus Technologies has received a $396,000 grant from the National Cancer Institute to develop a high-throughput screening system for cancer therapeutics.

The two-year grant will fund the further development of Platypus' Oris assay format into a 384-well cell migration assay suitable for high-throughput screening of chemical libraries for cancer therapeutics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.